What is Vivos?
Headquartered in Jersey City, Vivos has established itself as a cornerstone of the Life Sciences recruitment ecosystem since its inception in 1999. The company specializes in bridging the gap between high-caliber professionals and leading organizations across the pharmaceutical, biotechnology, and medical device sectors. Their comprehensive service portfolio encompasses staffing solutions, clinical services, and specialized IT support, all designed to facilitate innovation while maintaining rigorous regulatory compliance standards.
By focusing on results-driven outcomes, Vivos has cultivated a reputation for excellence, acting as a vital intermediary in an industry where specialized expertise is paramount. Their long-standing history of service delivery provides a stable foundation for their current enterprise-level growth phase, allowing them to adapt to the evolving demands of global health-tech and research environments.
How much funding has Vivos raised?
Vivos has raised a total of $717K across 2 funding rounds:
Debt
$350K
Debt
$367K
Debt (2020): $350K with participation from PPP
Debt (2021): $367K led by PPP
Key Investors in Vivos
PPP
Public-Private Partnership
What's next for Vivos?
With the recent infusion of capital, Vivos is poised to accelerate its strategic initiatives, particularly in the expansion of its clinical and IT service divisions. The company is expected to prioritize the enhancement of its digital infrastructure to better serve the growing demand for specialized talent in the biotech sector. Furthermore, the firm will likely focus on deepening its regulatory compliance capabilities, ensuring that its clients can navigate the increasingly complex landscape of global health regulations with agility.
As Vivos continues to scale, the focus will remain on maintaining the high-touch, quality-first approach that has defined its operations for over two decades. This strategic growth phase is anticipated to solidify the company's role as a primary workforce partner for enterprise-level organizations, driving long-term value for both its clients and the broader Life Sciences community.
